Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Expert Review of Clinical Immunology
|
May 19, 2010
Abatacept in the treatment of rheumatoid arthritis
Augusto Posadas, Jeffrey Lisse, Sujata Sarkar
Expert Review of Clinical Immunology
|
May 19, 2010
Discussion: DMARDs and biologic therapies in the management of inflammatory joint diseases
Austin Vaz, Jeffrey Lisse, Warren Rizzo, et al.
Drug Discovery Today
|
January 24, 2009
Biologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission
Willem van Eden, Jeffrey Lisse, Berent Prakken, et al.
Digestive Diseases and Sciences
|
May 7, 2002
Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography
Terry McNearney, Xuemei Lin, Jharana Shrestha, et al.
Rheumatology and Therapy
|
August 20, 2024
Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study
Abhijeet Danve, Aisha Vadhariya, Jeffrey Lisse, et al.
The Journal of Pain
|
November 19, 2003
Mechanical sensation and pain thresholds in patients with chronic arthropathies
J Amir Hendiani, Karin N Westlund, Nada Lawand, et al.
Rheumatology and Therapy
|
July 27, 2021
Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study
Theresa Hunter, Chi Nguyen, Julie Birt, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
March 13, 2009
Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients
Hilary G Flint-Wagner, Jeffrey Lisse, Timothy G Lohman, et al.
Advances in Therapy
|
March 5, 2024
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab
Sanjay Chabra, Julie Birt, Rebecca Bolce, et al.
The Lancet. Rheumatology
|
January 30, 2024
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis
Walter P Maksymowych, Xenofon Baraliakos, Robert G Lambert, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Expert Review of Clinical Immunology
|
May 19, 2010
Abatacept in the treatment of rheumatoid arthritis
Augusto Posadas, Jeffrey Lisse, Sujata Sarkar
Expert Review of Clinical Immunology
|
May 19, 2010
Discussion: DMARDs and biologic therapies in the management of inflammatory joint diseases
Austin Vaz, Jeffrey Lisse, Warren Rizzo, et al.
Drug Discovery Today
|
January 24, 2009
Biologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission
Willem van Eden, Jeffrey Lisse, Berent Prakken, et al.
Digestive Diseases and Sciences
|
May 7, 2002
Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography
Terry McNearney, Xuemei Lin, Jharana Shrestha, et al.
Rheumatology and Therapy
|
August 20, 2024
Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study
Abhijeet Danve, Aisha Vadhariya, Jeffrey Lisse, et al.
The Journal of Pain
|
November 19, 2003
Mechanical sensation and pain thresholds in patients with chronic arthropathies
J Amir Hendiani, Karin N Westlund, Nada Lawand, et al.
Rheumatology and Therapy
|
July 27, 2021
Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study
Theresa Hunter, Chi Nguyen, Julie Birt, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
March 13, 2009
Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients
Hilary G Flint-Wagner, Jeffrey Lisse, Timothy G Lohman, et al.
Advances in Therapy
|
March 5, 2024
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab
Sanjay Chabra, Julie Birt, Rebecca Bolce, et al.
The Lancet. Rheumatology
|
January 30, 2024
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis
Walter P Maksymowych, Xenofon Baraliakos, Robert G Lambert, et al.
Page
of 3